Aberrant NF-κB activity induces IL-6 and/or IL-10 production in a subset of DLBCL, which then activates the JAK/STAT pathway in an autocrine manner. The resulting synergistic NF-κB and STAT crosstalk affects lymphoma-cell survival, proliferation, and metabolism.